TABLE 3.
Effect of novobiocin on expression of cpxA, invG, and prgH
| Straina | Locus | Novobiocin concn (μg/ml) | Mean PhoA activity (Miller units)b ± SEM | 
|---|---|---|---|
| A1 | Z::TnphoA | 0 | 124 ± 10 | 
| 2 | 160 ± 5 | ||
| 5 | 38 ± 6 | ||
| 10 | 109 ± 6 | ||
| K14 | invG | 0 | 376 ± 47 | 
| 2 | 42 ± 0.2 | ||
| 5 | 39 ± 1 | ||
| 10 | 46 ± 3 | ||
| H5 | prgH | 0 | 928 ± 367 | 
| 2 | 53 ± 4 | ||
| 5 | 27 ± 1 | ||
| 10 | 29 ± 1 | ||
| I25 | cpxA | 0 | 127 ± 2 | 
| 2 | 177 ± 6 | ||
| 5 | 169 ± 7 | ||
| 10 | 119 ± 4 | 
Strains were grown to mid-logarithmic phase (OD600 of ≈0.6) in LB–0.3 M NaCl with or without various concentrations of novobiocin. Cell extracts were prepared by sonication, and the amount (milligrams) of protein was determined by the Bio-Rad assay.
Alkaline phosphatase activity was measured as described in Materials and Methods. The data represent means from two independent experiments.